DK0787142T3 - Neurturin og beslægtede vækstfaktorer - Google Patents
Neurturin og beslægtede vækstfaktorerInfo
- Publication number
- DK0787142T3 DK0787142T3 DK96932163T DK96932163T DK0787142T3 DK 0787142 T3 DK0787142 T3 DK 0787142T3 DK 96932163 T DK96932163 T DK 96932163T DK 96932163 T DK96932163 T DK 96932163T DK 0787142 T3 DK0787142 T3 DK 0787142T3
- Authority
- DK
- Denmark
- Prior art keywords
- neurturin
- methods
- growth factors
- vectors
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/519,777 US5739307A (en) | 1995-08-28 | 1995-08-28 | Polynucleotide encoding neurturin neurotrophic factor |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0787142T3 true DK0787142T3 (da) | 2006-05-29 |
Family
ID=24069730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96932163T DK0787142T3 (da) | 1995-08-28 | 1996-08-27 | Neurturin og beslægtede vækstfaktorer |
Country Status (12)
Country | Link |
---|---|
US (6) | US5739307A (ja) |
EP (1) | EP0787142B1 (ja) |
JP (1) | JP4222629B2 (ja) |
AT (1) | ATE315578T1 (ja) |
AU (1) | AU714107B2 (ja) |
CA (1) | CA2194172C (ja) |
DE (1) | DE69635738T2 (ja) |
DK (1) | DK0787142T3 (ja) |
IL (1) | IL122774A0 (ja) |
MX (1) | MX9800277A (ja) |
NZ (3) | NZ332921A (ja) |
WO (1) | WO1997008196A1 (ja) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743628B1 (en) * | 1995-08-28 | 2004-06-01 | Washington University | Method of cell culture using neurturin |
US6184200B1 (en) | 1995-09-28 | 2001-02-06 | Amgen Inc. | Truncated glial cell line-derived neurotrophic factor |
US6692943B1 (en) * | 1996-03-14 | 2004-02-17 | Washington University | Persephin and related growth factors |
US7015316B1 (en) | 1996-03-14 | 2006-03-21 | Washington University | Polynucleotides encoding human persephin and related growth factors |
US6222022B1 (en) | 1996-03-14 | 2001-04-24 | Washington University | Persephin and related growth factors |
DE69738074T2 (de) * | 1996-11-15 | 2008-05-21 | Genentech, Inc., South San Francisco | Reinigung von neurotrophinen |
EP0983296A4 (en) * | 1997-04-17 | 2002-11-06 | Univ Washington | RECEPTORS FOR TGF BETA RELATED NEUROTROPHIC FACTORS |
US7723473B2 (en) * | 1997-06-19 | 2010-05-25 | St. Louis University | Peptide antagonists of TGF-beta family members and therapeutic uses thereof |
US6043221A (en) * | 1997-07-30 | 2000-03-28 | Amgen Inc. | Method for preventing and treating hearing loss using a neuturin protein product |
SI1005358T1 (en) * | 1997-07-30 | 2003-06-30 | Amgen Inc. | Use of a neurturin protein product for preventing and treating hearing loss |
US6593133B1 (en) | 1998-07-06 | 2003-07-15 | Nsgene A/S | Neurotrophic factors |
US7067473B1 (en) * | 1998-07-14 | 2006-06-27 | Janssen Pharmaceutica N.V. | Neurotrophic growth factor |
IL140877A0 (en) * | 1998-07-14 | 2002-02-10 | Janssen Pharmaceutica Nv | Neurotrophic growth factor |
US6268352B1 (en) * | 1998-09-02 | 2001-07-31 | The Regents Of The University Of California | Promoters of neural regeneration |
US6284540B1 (en) | 1998-09-29 | 2001-09-04 | Washington University | Artemin, a novel neurotrophic factor |
DE69939484D1 (de) * | 1998-10-28 | 2008-10-16 | Cornell Res Foundation Inc | Methoden zur regulierung der angiogenese und vaskuläre integrität mittels trk rezeptor liganden bdnf, nt-3 und nt-4 |
EP1175433B1 (en) | 1999-05-04 | 2005-08-03 | Strakan International Limited | Androgen glycosides and androgenic activity thereof |
DE60032355T2 (de) * | 1999-05-17 | 2007-04-26 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Und Zum Vertrieb Von Pharmaka Mbh | NEUROPROTEKTIVE EIGENSCHAFTEN VON GDF-15, EINEM VERTRETER DER TGF-ß-SUPERFAMILIE |
WO2001034829A2 (en) * | 1999-11-05 | 2001-05-17 | The University Of Queensland | Nucleic acid sequence which encodes for an amino acid sequence capable of being cyclized within a cell or cell membrane |
US6866851B1 (en) | 1999-12-28 | 2005-03-15 | Washington University | GFRα1-RET specific agonists and methods therefor |
GB0024550D0 (ja) | 2000-10-06 | 2000-11-22 | Oxford Biomedica Ltd | |
US7442370B2 (en) | 2001-02-01 | 2008-10-28 | Biogen Idec Ma Inc. | Polymer conjugates of mutated neublastin |
US7276580B2 (en) | 2001-03-12 | 2007-10-02 | Biogen Idec Ma Inc. | Neurotrophic factors |
ATE526982T1 (de) | 2001-03-28 | 2011-10-15 | Biogen Idec Inc | Verwendung von neublastin-polypeptide zur behandlung von neuropathischen schmerzen |
US7658926B2 (en) * | 2001-09-14 | 2010-02-09 | Opexa Pharmaceuticals, Inc. | Autologous T-cell vaccines materials and methods |
US20050222070A1 (en) * | 2002-05-29 | 2005-10-06 | Develogen Aktiengesellschaft Fuer Entwicklungsbiologische Forschung | Pancreas-specific proteins |
AU2003238178A1 (en) * | 2002-05-29 | 2003-12-12 | Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung | Pancreas-specific proteins |
MXPA05001044A (es) * | 2002-08-08 | 2005-06-22 | Baylor College Medicine | Aislamiento e identificacion de celulas t. |
CA2864810A1 (en) | 2003-04-18 | 2004-11-04 | Biogen Idec Ma, Inc. | Polymer-conjugated glycosylated neublastin |
WO2004104172A2 (en) * | 2003-05-15 | 2004-12-02 | Bioarray Solutions, Ltd. | Hybridization-mediated analysis of polymorphisms |
ATE478092T1 (de) | 2003-06-10 | 2010-09-15 | Nsgene As | Verbesserte sekretion von neublastin |
CA2537960C (en) * | 2003-09-12 | 2012-01-10 | Stemcell Technologies Inc. | Neural colony forming assay |
US7598059B2 (en) | 2003-10-02 | 2009-10-06 | Biogen Idec Ma Inc. | Neublastin expression constructs |
AU2004283053A1 (en) | 2003-10-20 | 2005-05-06 | Nsgene A/S | In vivo gene therapy of Parkinson's Disease |
DE602004021847D1 (de) * | 2003-11-27 | 2009-08-13 | Develogen Ag | Verfahren zur prävention und behandlung von diabetes mit neurturin |
EP1784203B1 (en) | 2004-08-19 | 2010-06-30 | Biogen Idec MA Inc. | Refolding transforming growth factor beta family proteins |
EP1786454B1 (en) | 2004-08-19 | 2010-07-21 | Biogen Idec MA Inc. | Neublastin variants |
TWI501774B (zh) | 2006-02-27 | 2015-10-01 | Biogen Idec Inc | 神經性病症之治療 |
EP2016414B1 (en) * | 2006-05-05 | 2015-09-02 | Opexa Therapeutics | T-cell vaccine |
EP1872790A1 (en) | 2006-06-26 | 2008-01-02 | DeveloGen Aktiengesellschaft | New formulation for increasing bioavailability of neurturin |
EP2142205B1 (en) | 2007-05-01 | 2014-04-02 | Biogen Idec MA Inc. | Neublastin peptides for use in increasing vascularisation in tissue with impaired blood flow |
US8946201B2 (en) | 2007-08-27 | 2015-02-03 | Saint Louis University | Methods for inhibiting TGF-β |
EA201070484A1 (ru) | 2007-11-05 | 2011-04-29 | Девелоген Акциенгезельшафт | Новые конъюгаты нейртурина для фармацевтического применения |
WO2010033507A1 (en) | 2008-09-16 | 2010-03-25 | St. Louis University | Method of enhancing tgf-beta signalling |
ES2632431T3 (es) * | 2009-10-30 | 2017-09-13 | Ntf Therapeutics, Inc. | Moléculas de neurturina mejoradas |
US9127083B2 (en) | 2009-10-30 | 2015-09-08 | Ntf Therapeutics, Inc. | Neurturin molecules |
US8445432B2 (en) | 2009-10-30 | 2013-05-21 | Ntf Therapeutics Inc | Neurturin molecules |
US8564522B2 (en) * | 2010-03-31 | 2013-10-22 | Apple Inc. | Reduced-power communications within an electronic display |
EP2579899B1 (en) | 2010-06-14 | 2017-03-15 | F. Hoffmann-La Roche AG | Cell-penetrating peptides and uses thereof |
EP2394665A1 (en) * | 2010-06-14 | 2011-12-14 | F. Hoffmann-La Roche AG | Cell-penetrating peptides and uses therof |
US9869272B1 (en) | 2011-04-20 | 2018-01-16 | Martin A. Stuart | Performance of a transcritical or supercritical CO2 Rankin cycle engine |
EP2594295A1 (en) | 2011-11-16 | 2013-05-22 | Servicio Andaluz De Salud | Nerve implants based on a compacted biomaterial containing cells |
JP2019502674A (ja) * | 2015-08-25 | 2019-01-31 | ヒスタイド アクツィエンゲゼルシャフト | 組織形成誘導用化合物及びその使用 |
US11578110B2 (en) | 2015-08-25 | 2023-02-14 | Histide Ag | Compounds for inducing tissue formation and uses thereof |
EP3442559B1 (en) * | 2016-04-13 | 2024-05-01 | Chondropeptix B.V. | Bmp-7 derived peptides for use in a method of the treatment or prevention of osteoarthritis |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5141856A (en) * | 1989-01-05 | 1992-08-25 | Synergen, Inc. | Expression of purified ciliary neurotrophic factor |
US5011914A (en) * | 1989-01-05 | 1991-04-30 | Collins Franklin D | Purified ciliary neurotrophic factor |
US5260417A (en) * | 1989-04-03 | 1993-11-09 | Genetics Institute, Inc. | Megakaryocyte growth promoting activity protein |
US5235043A (en) * | 1990-04-06 | 1993-08-10 | Synergen, Inc. | Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins |
WO1993000616A1 (en) | 1991-06-29 | 1993-01-07 | Kao Corporation | Method of forming fixed images |
ES2225819T3 (es) * | 1991-09-20 | 2005-03-16 | Amgen Inc. | Factor neurotrofico de origen glial. |
EP0721464A4 (en) * | 1993-09-01 | 1998-12-30 | Start Technology Partnership | NEURON REGULATOR FACTOR FOR PROMOTING NEURON SURVIVAL |
AU1443095A (en) * | 1993-12-22 | 1995-07-10 | University Of Medicine And Dentistry Of New Jersey | Novel nucleic acid sequences isolated from glial cells |
US5759775A (en) * | 1994-10-27 | 1998-06-02 | Genetech, Inc. | Methods for detecting nucleic acids encoding AL--1 neurotrophic factor |
US6692943B1 (en) * | 1996-03-14 | 2004-02-17 | Washington University | Persephin and related growth factors |
-
1995
- 1995-08-28 US US08/519,777 patent/US5739307A/en not_active Expired - Lifetime
-
1996
- 1996-08-27 NZ NZ332921A patent/NZ332921A/en not_active IP Right Cessation
- 1996-08-27 DE DE69635738T patent/DE69635738T2/de not_active Expired - Lifetime
- 1996-08-27 EP EP96932163A patent/EP0787142B1/en not_active Expired - Lifetime
- 1996-08-27 NZ NZ318939A patent/NZ318939A/xx not_active IP Right Cessation
- 1996-08-27 CA CA2194172A patent/CA2194172C/en not_active Expired - Lifetime
- 1996-08-27 JP JP51062897A patent/JP4222629B2/ja not_active Expired - Lifetime
- 1996-08-27 IL IL12277496A patent/IL122774A0/xx not_active IP Right Cessation
- 1996-08-27 AU AU71054/96A patent/AU714107B2/en not_active Expired
- 1996-08-27 AT AT96932163T patent/ATE315578T1/de not_active IP Right Cessation
- 1996-08-27 NZ NZ332922A patent/NZ332922A/xx not_active IP Right Cessation
- 1996-08-27 WO PCT/US1996/014065 patent/WO1997008196A1/en active IP Right Grant
- 1996-08-27 DK DK96932163T patent/DK0787142T3/da active
- 1996-11-01 US US08/742,035 patent/US5747655A/en not_active Expired - Lifetime
- 1996-12-30 US US08/777,019 patent/US5817622A/en not_active Expired - Lifetime
- 1996-12-30 US US08/777,143 patent/US5843914A/en not_active Expired - Lifetime
- 1996-12-31 US US08/775,414 patent/US6090778A/en not_active Expired - Lifetime
-
1998
- 1998-01-07 MX MX9800277A patent/MX9800277A/es unknown
-
1999
- 1999-12-30 US US09/476,290 patent/US7015311B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4222629B2 (ja) | 2009-02-12 |
NZ318939A (en) | 1999-01-28 |
CA2194172C (en) | 2012-07-10 |
US5747655A (en) | 1998-05-05 |
AU714107B2 (en) | 1999-12-16 |
DE69635738D1 (de) | 2006-04-06 |
EP0787142A4 (en) | 1999-04-07 |
CA2194172A1 (en) | 1997-03-01 |
ATE315578T1 (de) | 2006-02-15 |
US5817622A (en) | 1998-10-06 |
MX9800277A (es) | 1998-09-30 |
AU7105496A (en) | 1997-03-19 |
IL122774A0 (en) | 1998-08-16 |
EP0787142A1 (en) | 1997-08-06 |
US7015311B1 (en) | 2006-03-21 |
EP0787142B1 (en) | 2006-01-11 |
NZ332922A (en) | 1999-07-29 |
US5739307A (en) | 1998-04-14 |
JPH11512928A (ja) | 1999-11-09 |
NZ332921A (en) | 2001-03-30 |
US5843914A (en) | 1998-12-01 |
DE69635738T2 (de) | 2006-08-31 |
US6090778A (en) | 2000-07-18 |
WO1997008196A1 (en) | 1997-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0787142T3 (da) | Neurturin og beslægtede vækstfaktorer | |
DE69731834D1 (de) | Agouti verwandtes gen | |
NO20065528L (no) | Forbindelser som fremmer vevsvekst. | |
EP0861894A4 (en) | POLYPEPTIDE THAT SUPPRESSES DIFFERENTIATION | |
NZ279963A (en) | Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946 | |
EP2189475A3 (en) | Fibroblast growth factor-like polypeptides | |
Neuhaus et al. | The human connexin32 gene is transcribed from two tissue-specific promoters | |
WO2002061076A1 (en) | Adiponectin-associated protein | |
EP0886651A4 (en) | PERSEPHIN AND ASSOCIATED GROWTH FACTORS | |
IL133834A0 (en) | Persephin and related growth factors | |
WO1995030001A3 (en) | Novel p-selectin ligand protein | |
NZ334970A (en) | Human growth gene and short stature gene region using sequence derived from the SHOX gene | |
EP0816504A3 (en) | Platelet activating factor acetylhdrolase, and gene thereof | |
Falaschi et al. | The three DNA polymerases of animal cells: properties and functions | |
RU2003123108A (ru) | Мутантные формы человеческого белка fgf23, снижающие содержание фосфора в крови | |
EP0990000A4 (en) | CONJUNCTIVE TISSUE GROWTH FACTOR 3 | |
WO1998031817A3 (en) | Human lysosomal sialidase and therapeutic uses thereof | |
WO2002016419A3 (en) | Progression suppressed gene 13 (psgen 13) and uses thereof | |
ATE479753T1 (de) | Menschliches tsc403 gen | |
Li et al. | Cloning and sequence analysis of two embryonic β-like globin cDNAs (y and z) of hamster | |
EP0787798A3 (en) | GRP17 gene | |
CA1156166A (en) | Recombinant bacterial plasmids containing the coding sequences of insulin genes | |
Skamrov et al. | Determination of the nucleotide sequence of the part of the Mycoplasma gallisepticum genome, containing the rpoB gene, during the use of the Bal-pTM method for obtaining sequential deletions of the sequenced fragment | |
WO1999043834A3 (en) | P-selectin ligand protein, including tetrameric fusion proteins | |
PT89511A (pt) | Processo para a preparacao de anfiregulina, um regulador bifuncional do crescimento de celulas |